The emerging therapy of this peptide represents a exciting development in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide affects two pathways – GLP-1 and the GIP hormone – resulting in improved glucose management and possible weight reduction. Scientists are exploring its future benefits and place in the complete